Topic
Addiction medicine
About: Addiction medicine is a research topic. Over the lifetime, 1070 publications have been published within this topic receiving 23685 citations.
Papers published on a yearly basis
Papers
More filters
01 Jan 2014
TL;DR: Drug addiction is often treated as a subcategory of mental illness, and insurance plans group them together under the rubric of “behavioral health.”
Abstract: Objective: Public attitudes about drug addiction and mental illness were compared. Methods: AW ebbased national survey (N5709) was conducted to compare attitudes about stigma, discrimination, treatment effectiveness, and policy support in regard to drug addiction and mental illness. Results: Respondents held significantly more negative views toward persons with drug addiction. More respondents were unwilling to have a person with drug addiction marry into their family or work closely with them. Respondents were more willing to accept discriminatory practices against persons with drug addiction, more skeptical about the effectiveness of treatments, and more likely to oppose policies aimed at helping them. Conclusions: Drug addiction is often treated as a subcategory of mental illness, and insurance plans group them together under the rubric of “behavioral health.”Given starkly different publicviews about drug addiction and mental illness, advocates may need to adopt differing approaches to reducing stigma and advancing public policy. (Psychiatric Services 65:1269–1272, 2014; doi: 10.1176/ appi.ps.201400140)
1 citations
01 Apr 2020
TL;DR: In this paper, a global study has been designed and conducted by the International Society of Addiction Medicine Practice and Policy Interest Group (ISAM-PPIG) to understand better the health related issues of people with Substance Use Disorders (SUD) as well as responses of the relevant health care systems during the pandemic.
Abstract: pandemic affected all parts of the global communities and the health of substance users are potentially at a greater risk of harm. This global study has been designed and conducted by the International Society of Addiction Medicine Practice and Policy Interest Group (ISAM-PPIG) to understand better the health related issues of people with Substance Use Disorders (SUD) as well as responses of the relevant health care systems during the pandemic. Methods: This is a cross-sectional study using convenient sampling. The data gathering was carried out with two follow-up stages each two months apart through an online conducted survey prepared using Google platform. The survey started by emergence of COVID-19 as a pandemic in March 2020 and respondents were followed till September 2020 when most of the initial lockdowns by most countries are supposed to be reopened. Ethics and Dissemination: The study was approved by the ethics committee of University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. The results will be published in relevant peer reviewing journals and communicated with different international stakeholders.
1 citations
TL;DR: In this paper , the importance of clinicians, particularly addiction clinicians, to be educated about both harmful and beneficial effects of cannabis and related products before making therapeutic recommendations is emphasized, and the authors emphasize the need for clinicians to be informed about both beneficial and harmful effects of drugs.
Abstract:
This Viewpoint communicates the importance of clinicians, particularly addiction clinicians, to be educated about both harmful and beneficial effects of cannabis and related products before making therapeutic recommendations.
1 citations